Structural and functional changes in the gut microbiota associated to Clostridium difficile infection

Frontiers in Microbiology

Volumn 5, Issue JULY, 2014, Pages

  Pérez Cobas, Ana E ^a,b   Artacho, Alejandro ^a   Ott, Stephan J ^c,d   Moya, Andrés ^a,b   Gosalbes, María J ^a,b   Latorre, Amparo ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Bacterial composition; C. difficile infection; Colonization resistance; Gut microbiota; Metabolic functions

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFAZOLIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; MOXIFLOXACIN; SULBACTAM; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BIODIVERSITY; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; ECOLOGICAL GENETICS; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; INTESTINE FLORA; METAGENOMICS; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 84905402416     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00335     Document Type: Article

References (74)

1. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403-410. doi: 10.1016/s0022-2836(05)80360-2
2. Antharam, V. C., Li, E. C., Ishmael, A., Sharma, A., Mai, V., Rand, K. H., et al. (2013). Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea." J. Clin. Microbiol. 51, 2884-2892. doi: 10.1128/JCM.00845-13
3. Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L., and Young, V. B. (2009). Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 77, 2367-2375. doi: 10.1128/IAI.01520-08
4. Antunes, L. C., Han, J., Ferreira, R. B., Lolic, P., Borchers, C. H., and Finlay, B. B. (2011). Effect of antibiotic treatment on the intestinal metabolome. Antimicrob. Agents Chemother. 55, 1494-1503. doi: 10.1128/AAC.01664-10
5. Banerjee, P., Merkel, G. J., and Bhunia, A. K. (2009). Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog. 1:8. doi: 10.1186/1757-4749-1-8
6. Barcenilla, A., Pryde, S. E., Martin, J. C., Duncan, S. H., Stewart, C. S., Henderson, C., et al. (2000). Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 66, 1654-1661. doi: 10.1128/AEM.66.4.1654-1661.2000
7. Bartlett, J. G. (2002). Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med. 346, 334-339. doi: 10.1056/NEJMcp011603
8. Britton, R. A., and Young, V. B. (2012). Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 20, 313-319. doi: 10.1016/j.tim.2012.04.001
9. Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., et al. (2010). QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-346. doi: 10.1038/nmeth.f.303
10. Chao, A. (1984). Nonparametric estimation of the number of classes in a population. Scand. J. Stat. 11, 256-270.
11. Chao, A., Wen-Han, H., Chen, Y. C., and Kuo, C. Y. (2000). Estimating the number of shared species in two communities. Stat. Sin. 10, 227-246.
12. Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., et al. (2010). Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31, 431-455. doi: 10.1086/651706
13. Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., et al. (2009). The Ribosomal database project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37, D141-5. doi: 10.1093/nar/gkn879
14. Collins, M. D., Lawson, P. A., Willems, A., Cordoba, J. J., Fernandez-Garayzabal, J., Garcia, P., et al. (1994).The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44, 812-826. doi: 10.1099/00207713-44-4-812
15. Dethlefsen, L., Huse, S., Sogin, M. L., and Relman, D. A. (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:280. doi: 10.1371/journal.pbio.0060280
16. Dethlefsen, L., and Relman, D. A. (2010). Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4554-4561. doi: 10.1073/pnas.1000087107
17. Deutscher, J., Francke, C., and Postma, P. W. (2006). How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol. Mol. Biol. Rev. 4, 939-1031. doi: 10.1128/MMBR.00024-06
18. Donskey, C. J. (2004). The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis. 39, 219-226. doi: 10.1086/422002
19. Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Salgado, P., Ponce, M., Ponce, J., et al. (2012). Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ. Microbiol. Rep. 4, 242-247. doi: 10.1111/j.1758-2229.2012.00327.x
20. Durbin, R., Eddy, S. R., Krogh, A., and Mitchison, G. (1998). Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids. Cambridge: Cambridge University Press.
21. Gill, S. R., Pop, M., Deboy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., et al. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359. doi: 10.1126/science.1124234
22. Gómez-Alvarez, V., Teal, T. K., and Schmidt, T. M. (2009). Systematic artifacts in metagenomes from complex microbial communities. ISME J. 3, 1314-1317. doi: 10.1038/ismej.2009.72
23. Gómez-Gallego, C., Collado, M. C., Ilo, T., Jaakkola, U. M., Bernal, M. J., Periago, M. J., et al. (2012). Infant formula supplemented with polyamines alters the intestinal microbiota in neonatal BALB/cOlaHsd mice. J. Nutr. Biochem. 23, 1508-1513. doi: 10.1016/j.jnutbio.2011.10.003
24. Gosalbes, M. J., Durbán, A., Pignatelli, M., Abellan, J. J., Jiménez-Hernández, N., Pérez-Cobas, A. E., et al. (2011). Metatranscriptomic approach to analyze the functional human gut microbiota. PLoS ONE 6:17447. doi: 10.1371/journal.pone.0017447
25. Guarner, F., and Malagelada, J. R. (2003). Gut flora in health and disease. Lancet 361, 512-519. doi: 10.1016/S0140-6736(03)12489-0
26. Haft, D. H., Selengut, J. D., and White, O. (2003). The TIGRFAMs database of protein families. Nucleic Acids Res. 31, 371-373. doi: 10.1093/nar/gkg128
27. Hattori, M., and Taylor, T. D. (2009). The human intestinal microbiome: a new frontier of human biology. DNA Res. 16, 1-12. doi: 10.1093/dnares/dsn033
28. Hookman, P., and Barkin, J. S. (2009). Clostridium difficile associated infection, diarrhea and colitis. World J. Gastroenterol. 15, 1554-1580. doi: 10.3748/wjg.15.1554
29. Hooper, L. V., Midtvedt, T., and Gordon, J. I. (2002). How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283-307. doi: 10.1146/annurev.nutr.22.011602.092259
30. Itoh, K., Lee, W. K., Kawamura, H., Mitsuoka, T., and Magaribuchi, T. (1987). Intestinal bacteria antagonistic to Clostridium difficile in mice. Lab. Anim. 21, 20-25. doi: 10.1258/002367787780740662
31. Jakobsson, H. E., Jernberg, C., Andersson, A. F., Sjölund-Karlsson, M., Jansson, J. K., and Engstrand, L. (2010). Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5:9836. doi: 10.1371/journal.pone.0009836
32. Jernberg, C., Löfmark, S., Edlund, C., and Jansson, J. K. (2010). Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156, 3216-3223. doi: 10.1099/mic.0.040618-0
33. Jung, I. L., Oh, T. J., and Kim, I. G. (2003). Abnormal growth of polyamine-deficient Escherichia coli mutant is partially caused by oxidative stress-induced damage. Arch. Biochem. Biophys. 418, 125-132. doi: 10.1016/j.abb.2003.08.003
34. Kang, S., Denman, S. E., Morrison, M., Yu, Z., Dore, J., Leclerc, M., et al. (2010). Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm. Bowel Dis. 16, 2034-2042. doi: 10.1002/ibd.21319
35. Kristiansson, E., Hugenholtz, P., and Dalevi, D. (2009). ShotgunFunctionalizeR: an R-package for functional comparison of metagenomes. Bioinformatics 25, 2737-2738. doi: 10.1093/bioinformatics/btp508
36. Kurokawa, K., Itoh, T., Kuwahara, T., Oshima, K., Toh, H., Toyoda, A., et al. (2007). Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14, 169-181. doi: 10.1093/dnares/dsm018
37. Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., et al. (2012). Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8:1002995. doi: 10.1371/journal.ppat.1002995
38. Leser, T. D., and Mølbak, L. (2009). Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. Environ. Microbiol. 11, 2194-2206. doi: 10.1111/j.1462-2920.2009.01941.x
39. Lozupone, C., Faust, K., Raes, J., Faith, J. J., Frank, D. N., Zaneveld, J., et al. (2012). Identifying genomic and metabolic features that can underlie early successional and opportunistic lifestyles of human gut symbionts. Genome Res. 22, 1974-1984. doi: 10.1101/gr.138198.112
40. May, T., Mackie, R. I., Fahey, G. C. Jr., Cremin, J. C., and Garleb, K. A. (1994). Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand. J. Gastroenterol. 29, 916-922. doi: 10.3109/00365529409094863
41. Merrigan, M. M., Sambol, S. P., Johnson, S., and Gerding, D. N. (2003). Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters. J. Infect. Dis. 188, 1922-1927. doi: 10.1086/379836
42. Montalto, M., D'Onofrio, F., Gallo, A., Cazzato, A., and Gasbarrini, G. (2009). Intestinal microbiota and its functions. Dig. Liver Dis. Suppl 3, 30-34 doi: 10.1016/S1594-5804(09)60016-4
43. Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., et al. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13:79. doi: 10.1186/gb-2012-13-9-r79
44. Naaber, P., Smidt, I., Stsepetova, J., Brilene, T., Annuk, H., and Mikelsaar, M. J. (2004). Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. Med. Microbiol. 53, 551-554. doi: 10.1099/jmm.0.45595-0
45. Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., et al. (2013). Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99. doi: 10.1038/nature12503
46. Oksanen, J., Blanchet, F. G., Kindt, R., Legendre, P., O'Hara, R. B., Minchin, P. R., et al. (2011). Vegan: Community Ecology Package. R package version 1.17-9. Available online at: http://CRAN.R-project.org/package=vegan
47. Pérez-Cobas, A. E., Artacho, A., Knecht, H., Friedrichs, A., Ott, S. J., Moya, A., et al. (2013b). Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS ONE 8:80201. doi: 10.1371/journal.pone.0080201
48. Pérez-Cobas, A. E., Gosalbes, M. J., Friedrichs, A., Knecht, H., Artacho, A., Eismann, K., et al. (2013a). Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62, 1591-1601. doi: 10.1136/gutjnl-2012-303184
49. Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S., and Flint, H. J. (2002). The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett. 217, 133-139. doi: 10.1016/S0378-1097(02)01106-0
50. R Development Core Team. (2011). R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing. Available online at: http://www.R-project.org/
51. Rea, M. C., Dobson, A., O'Sullivan, O., Crispie, F., Fouhy, F., Cotter, P. D., et al. (2011). Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4639-4644. doi: 10.1073/pnas.1001224107
52. Reeves, A. E., Koenigsknecht, M. J., Bergin, I. L., and Young, V. B. (2012). Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect. Immun. 80, 3786-3794. doi: 10.1128/IAI.00647-12
53. Reeves, A. E., Theriot, C. M., Bergin, I. L., Huffnagle, G. B., Schloss, P. D., and Young, V. B. (2011). The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes 2, 145-158. doi: 10.4161/gmic.2.3.16333
54. Relman, D. A. (2012). The human microbiome: ecosystem resilience and health. Nutr. Rev. 70(Suppl), 2-9. doi: 10.1111/j.1753-4887.2012.00489.x
55. Roy, C. C., Kien, C. L., Bouthillier, L., and Levy, E. (2006). Short-chain fatty acids: ready for prime time? Nutr. Clin. Pract. 21, 351-366. doi: 10.1177/0115426506021004351
56. Sambol, S. P., Merrigan, M. M., Tang, J. K., Johnson, S., and Gerding, D. N. (2002). Colonization for the prevention of Clostridium difficile disease in hamsters. J. Infect. Dis. 186, 1781-1789. doi: 10.1086/345676
57. Scutari, M. (2010). Learning Bayesian Networks with the bnlearn R Package. J. Stat. Softw. 35, 1-22. Available online at: http://www.jstatsoft.org/v35/i03/
58. Sekirov, I., Russell, S. L., Antunes, L. C., and Finlay, B. B. (2010). Gut microbiota in health and disease. Physiol. Rev. 90, 859-904. doi: 10.1152/physrev.00045.2009
59. Shanahan, F. (2013). The colonic microbiota in health and disease. Curr. Opin. Gastroenterol. 29, 49-54. doi: 10.1097/MOG.0b013e32835a3493
60. Shannon, C. E. (1948). A mathematical theory of communication. Bell Syst. Tech. J. 27, 379-423. doi: 10.1002/j.1538-7305.1948.tb01338.x
61. Shepard, W., Soutourina, O., Courtois, E., England, P., Haouz, A., and Martin-Verstraete, I. (2011). Insights into the Rrf2 repressor family-the structure of CymR, the global cysteine regulator of Bacillus subtilis. FEBS J. 278, 2689-2701. doi: 10.1111/j.1742-4658.2011.08195.x
62. Stecher, B., and Hardt, W. D. (2011). Mechanisms controlling pathogen colonization of the gut. Curr. Opin. Microbiol. 14, 82-91. doi: 10.1016/j.mib.2010.10.003
63. Suzuki, R., and Shimodaira, H. (2006). Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22, 1540-1542. doi: 10.1093/bioinformatics/btl117
64. Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J. P., et al. (2009). Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 11, 2574-2584. doi: 10.1111/j.1462-2920.2009.01982.x
65. Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E. Jr., Hatton, G. E., Nelson, A. M., Li, B., et al. (2014). Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5, 3114. doi: 10.1038/ncomms4114
66. Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., et al. (2010). Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120, 4332-4341. doi: 10.1172/JCI43918
67. Urich, T., Lanzén, A., Qi, J., Huson, D. H., Schleper, C., and Schuster, S. C. (2008). Simultaneous assessment of soil microbial community structure and function through analysis of the meta-transcriptome. PLoS ONE 3:2527. doi: 10.1371/journal.pone.0002527
68. Vincent, C., Stephens, D. A., Loo, V. G., Edens, T. J., Behr, M. A., Dewar, K., et al. (2013). Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome 1:18. doi: 10.1186/2049-2618-1-18
69. Vollaard, E. J., and Clasener, H. A. (1994). Colonization resistance. Antimicrob. Agents Chemother. 38, 409-414. doi: 10.1128/AAC.38.3.409
70. Willing, B. P., Russell, S. L., and Finlay, B. B. (2011). Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 9, 233-243. doi: 10.1038/nrmicro2536
71. Wouters, M. A., Fan, S. W., and Haworth, N. L. (2010). Disulfides as redox switches: from molecular mechanisms to functional significance. Antioxid. Redox. Signal. 12, 53-91. doi: 10.1089/ARS.2009.2510
72. Wu, S., Zhu, Z., Fu, L., Niu, B., and Li, W. (2011). WebMGA: a customizable web server for fast metagenomic sequence analysis. BMC Genomics 12:444. doi: 10.1186/1471-2164-12-444.
73. Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., et al. (2013).Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372-385. doi: 10.1016/j.immuni.2013.08.003
74. Zoetendal, E. G., Rajilic-Stojanovic, M., and de Vos, W. M. (2008). High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615. doi: 10.1136/gut.2007.133603